近日，富卫集团有限公司（以下简称"富卫集团"）四度向港交所递交了上市申请，拟在港交所主板挂牌上市，由摩根士丹利及高盛担任联席保荐人。 富卫集团是一家泛亚洲人寿保险公司，采用以客为先及数码赋能的模式。公司目前已在泛亚地区建立业务，遍布香港（及澳门）、泰国（及柬埔寨）、日本 及新兴市场（包括菲律宾、印尼、新加坡、越南及马来西亚）。富卫集团采用多渠道分销模式，投资于数码基础设施及数据分析能力，并扩大合作及转介机 会。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 出品：新浪财经上市公司研究院 作者：喜乐 2024年，公司净利润虽然扭亏为盈，但也仅录得0.1亿美元的净利润，且其主要来源于净投资业绩的改善，从2023年的-6.32亿美元至2024年的2.41亿美元。 而其最重要的保险服务业绩甚至还有一定程度的下滑，从2023年的6.79亿美元下滑至2024年的6.70亿美元。 富卫集团在亚洲市场的版图扩张主要依赖收购策略。2013年，李嘉诚次子李泽楷收购荷兰国际集团香港、澳门及泰国保险业务。自2015年起，富卫集团先后 收购PT Finansial Wiramitra Danadyaksa、 ...

Meeting Announcement - The company will hold its second extraordinary general meeting of shareholders for 2025 on June 27, 2025, at 14:30 [1] - The meeting will include both on-site and online voting options for shareholders [2][8] Voting Procedures - Shareholders can participate in voting either by attending in person or by authorizing a proxy [2] - Online voting will be available through the Shenzhen Stock Exchange trading system and internet voting system during specified time slots on the meeting day [1][2] Agenda Items - The meeting will discuss several proposals, including the issuance of H shares and related matters [4][5][12] - Proposals require different voting methods, with some needing special resolutions that require a two-thirds majority [7] Registration and Attendance - Shareholders must register for the meeting by providing necessary documentation, including identification and proof of shareholding [3][6] - The meeting will last for half a day, and attendees will bear their own travel and accommodation costs [3][6]

院和秘密封景 商店 副社会 智能社 改造日 aksmice 加盟 取ლ者也 CANNERSES 日报网外国际acchin 足田湖日产 09:46 自动球排球32 1982年8月 019 雷巴多榜 contraction of the (TV) 上市这事，在外人眼里看着光鲜亮丽，可真轮到自己头上，那滋味就像打翻了五味瓶，酸甜苦辣咸样样俱全。有人说上市是鲤鱼跃龙门，也有人说这是把双 刃剑，舞不好就容易伤了自己。公司上市到底是馅饼还是陷阱。 先说上市的甜头。企业发展到一定阶段，就像长身体的孩子，得不断 "输血" 才能茁壮成长。上市就好比打开了一个聚宝盆，通过发行股票能一下子募集到 巨额资金。这笔钱不仅能用来扩大生产规模、升级技术设备，还能在市场寒冬时帮企业挺过难关。就拿华鲁恒升化工来说，上市后短短几年销售额从 4.5 亿 飙升到 34 亿，这就是资本的力量。而且上市后，企业就像站在了聚光灯下，股民的关注、媒体的报道，无形中成了免费的广告，品牌知名度和社会影响力 蹭蹭往上涨。招投标更容易了，人才也更愿意来，这都是实实在在的好处。 不过，上市这事儿也不是全是阳光彩虹。上市就意味着要把自己的家底儿亮出来，财务数据、经营策 ...

Core Viewpoint - Stone Technology plans to issue H-shares and list on the Hong Kong Stock Exchange, aiming to consider the interests of existing shareholders and market conditions during the issuance period [1][2] Group 1: H-share Issuance and Listing - The company held board and supervisory meetings on June 6, 2025, to approve the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange [1][2] - The company is actively discussing related work with intermediaries regarding the H-share issuance and listing, with specific details yet to be determined [1] Group 2: Shareholder Actions and Stock Performance - The largest shareholder, Chang Jing, reduced his stake from 23.15% to 21.03% between March 31, 2023, and September 30, 2024, cashing out approximately 888 million yuan [2] - In the past six months, Chang Jing sold 1.3124 million shares, representing a 1% reduction, totaling nearly 392 million yuan, and later sold another 1.3158 million shares for about 496 million yuan [3] Group 3: Financial Performance - In 2024, the company reported revenue of 11.945 billion yuan, a year-on-year increase of 38.03%, while net profit attributable to shareholders decreased by 3.64% to 1.977 billion yuan [4] - The net cash flow from operating activities was 1.734 billion yuan, down 20.68% year-on-year [4] Group 4: Historical Stock Information - The company's stock reached a historical high of 1,494.99 yuan on June 21, 2021, but closed at 222.70 yuan on June 6, 2025, reflecting a decline of 57.93% [2]

"80后"上任财务总监 万联证券官网显示，该公司目前共9名高管，包括总裁1名、副总裁1名（兼董事会秘书）、合规总监1 名、首席信息官1名、首席风险官1名、财务总监1名，总裁助理3名。被解聘公司财务总监前，刘康莉身 兼三职——万联证券副总裁、财务总监、董事会秘书，是该公司公示的高管名单中职务最多的。 | 公司高管 | | | --- | --- | | 姓名 | 职务 | | 张毅峰 | 总裁 | | 刘康莉 | 副总裁、董事会秘书 | | 榜车飞 | 合规总监 | | 钟晖霖 | 总裁助理 | | 李滇 | 总裁助理 | | 陈卓权 | 首席信息官 | | 林创坚 | 首席风险官 | | 蔡昭鹏 | 总裁助理 | | 蔡荣 | 财务总监 | 日前，万联证券发布关于公司财务负责人变动公告。万联证券董事会同意解聘刘康莉的公司财务总监职 务；同意聘任蔡荣为公司财务总监。公告显示，被解聘公司财务总监后，刘康莉继续担任公司副总裁、 董事会秘书等职务；蔡荣任公司财务总监、兼任人力资源部总经理等。 信息来源：万联证券官网 据公告，刘康莉1977年9月出生，此前曾任方正证券广东分公司机构业务岗、副总经理（主持工作）、 联席总 ...

翰思艾泰生物医药科技（武汉）股份有限公司向港交所提交上市申请书 智通财经6月2日电，利弗莫尔证券显示，翰思艾泰生物医药科技（武汉）股份有限公司向港交所提交上 市申请书，独家保荐人为中信证券。 ...

Core Viewpoint - Zhongke Tongda (688038.SH) reported a significant increase in operating revenue for 2024, achieving 343 million yuan, a year-on-year growth of 56.27%, while still facing a net loss attributed to shareholders of 18.1 million yuan, although this is an improvement from the previous year's loss of 102.5 million yuan [1][2]. Financial Performance - Operating revenue for 2024 reached 343 million yuan, up 56.27% from 219 million yuan in 2023 [1][2]. - The net profit attributable to shareholders was -18.1 million yuan, compared to -102.5 million yuan in the previous year [1][2]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was -19.7 million yuan, an improvement from -108 million yuan in 2023 [1][2]. - The net cash flow from operating activities was 27.6 million yuan, a significant recovery from -91.7 million yuan in the previous year [1][2]. Historical Comparison - In 2023, the operating revenue was 219 million yuan, which represented a decline of 43.96% from 391 million yuan in 2022 [3]. - The net profit attributable to shareholders in 2023 was -102.5 million yuan, compared to -8.4 million yuan in 2022 [3]. - The net cash flow from operating activities in 2023 was -91.7 million yuan, an improvement from -126 million yuan in 2022 [3]. Recent Quarterly Performance - In the first quarter of 2025, the company reported operating revenue of 37.5 million yuan, a decrease of 31.04% year-on-year [4]. - The net profit attributable to shareholders for the first quarter of 2025 was 4.6 million yuan, a year-on-year increase of 7.79% [4]. - The net cash flow from operating activities for the first quarter of 2025 was 2.5 million yuan, a recovery from -28.9 million yuan in the same period last year [4]. Capital Raising and Listing Information - Zhongke Tongda was listed on the Sci-Tech Innovation Board on July 13, 2021, with an issuance of 29.1 million shares at a price of 8.60 yuan per share, raising a total of 250 million yuan [5]. - The net amount raised was 199 million yuan after deducting issuance costs, which were 51.2 million yuan [5]. - The company’s final net fundraising amount was 1.81 billion yuan less than the original plan of 3.80 billion yuan [5].

消息人士：希音计划在未来几周内提交香港上市的招股说明书，希音此前其在伦敦的IPO计划遇阻。 ...

马斯克：星链未来有可能上市。 ...

Group 1 - FWD Group has submitted an IPO application to the Hong Kong Stock Exchange, with Morgan Stanley and Goldman Sachs as joint sponsors, after previously seeking a listing in the US [2] - The company is expected to have a valuation of up to $9 billion (HKD 70.2 billion), depending on market conditions at the time of the transaction [2] - FWD Group has attempted to list in Hong Kong multiple times, with previous applications submitted in February, September 2022, and March 2023, all of which were unsuccessful [2] Group 2 - Financial performance shows FWD Group's net insurance and investment results for 2022, 2023, and 2024 at $493 million, $47 million, and $911 million respectively, with net profits of -$320 million, -$717 million, and $10 million [3] - The Hong Kong capital market is experiencing a strong recovery, with 17 new listings in the first quarter of 2025, raising a total of HKD 17.68 billion, a 2.69 times increase from the previous year [3] - The forecast for the Hong Kong IPO market in 2025 is approximately 80 new listings, with expected fundraising between HKD 130 billion to HKD 150 billion [3] Group 3 - FWD Group operates as a rapidly growing pan-Asian life insurance company, offering a range of products including participating and non-participating life insurance, medical insurance, investment-linked life insurance, and group insurance across ten markets [5] - The company's main product categories contribute to new business value in 2024 as follows: participating life insurance (36.5%), non-participating life insurance (28.0%), critical illness and term life insurance (22.2%), medical and supplementary insurance (7.5%), and group insurance (5.7%) [5] - FWD Group has initiated a $5 billion global medium-term note and capital securities program, which is expected to be effective for 12 months starting from March 28 [5]